COVID-19 and diabetes: What does the clinician need to know?
Open Access
- 3 July 2020
- journal article
- review article
- Published by Elsevier BV in Primary Care Diabetes
- Vol. 14 (5), 558-563
- https://doi.org/10.1016/j.pcd.2020.06.010
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2016
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMCNature, 2013
- State of the art paper Biochemistry of adipose tissue: an endocrine organVideosurgery and Other Miniinvasive Techniques, 2013
- Infections in patients with diabetes mellitus: A review of pathogenesisIndian Journal of Endocrinology and Metabolism, 2012
- Diabetes and the Severity of Pandemic Influenza A (H1N1) InfectionDiabetes Care, 2010
- Glucose Control and Mortality in Critically Ill PatientsPublished by American Medical Association (AMA) ,2003
- Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)Thorax, 2003
- Diabetes and the Risk of Infection-Related Mortality in the U.S.Diabetes Care, 2001
- Diabetes mellitusJournal of Diabetes and its Complications, 2001
- Immune dysfunction in patients with diabetes mellitus (DM)FEMS Immunology & Medical Microbiology, 1999